Menu

Experience

Matthew D. Silverman

    • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 


    • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 


    • Amazon to Acquire One Medical for $3.9 Billion 


    • Digital Shadows Agrees to Sell to ReliaQuest 


    • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 


    • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 


    • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 


    • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 


    • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 


    • Cornerstone OnDemand Agrees to Sell to Clearlake Capital Group for $5.2 Billion 


    • One Medical Agrees to Acquire Iora Health in $2.1 Billion Transaction 


    • IonQ Agrees to SPAC Merger With dMY Technology Group III 


    • Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company 


    • Horizon Therapeutics to Acquire Viela Bio 


    • Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion 


    • Sunrun to Acquire Vivint Solar for Enterprise Value of $3.2 Billion 


    • Portola Agrees to Sell to Alexion for $1.41 Billion 


    • Forty Seven Agrees to Sell to Gilead for $4.9 Billion  


    • Avedro Sells to Glaukos 


    • Tableau Enters Agreement to Sell to Salesforce for $15.7 Billion 


    • Aquantia Sells to Marvell Technologies for $452 Million 


    • Immune Design Sale to Merck for $300 Million 


    • Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out 


    • SELLAS Life Sciences Group to Merge with Galena Biopharma 


    • ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion 


    • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 


    • Sazerac to Acquire Southern Comfort + Tuaca for $544 Million 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • Dot Hill Systems sale to Seagate Technology 


    • Auspex Pharma $3.5 billion sale to Teva Pharma 


    • Auspex Pharma Acquired by Teva for $3.5 Billion 


    • Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion